Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 750 of 866 entries
View as:

A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection

Phase: N/A Priority: Normal
NCT ID: NCT03222583 Org: User:
Start: 10/04/17 End: 02/15/19 Due: 02/15/20

A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT02756611 Org: User:
Start: 06/22/16 End: 03/11/22 Due: 03/11/23

Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT02939989 Org: User:
Start: 11/21/16 End: 07/30/21 Due: 07/30/22

A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04196283 Org: User:
Start: 01/22/20 End: 10/27/22 Due: 10/27/23

Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT05216263 Org: User:
Start: 03/22/22 End: 05/02/25 Due: 05/02/26

Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT02343406 Org: User:
Start: 02/17/15 End: 06/24/19 Due: 06/24/20

An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01969695 Org: User:
Start: 12/20/13 End: 12/16/19 Due: 12/16/20

A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT06109272 Org: User:
Start: 01/11/24 End: 09/30/30 Due: 09/30/31

A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With Linaclotide

Phase: N/A Priority: Normal
NCT ID: NCT05760313 Org: User:
Start: 04/27/23 End: 06/09/25 Due: 06/09/26

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT06568939 Org: User:
Start: 01/20/25 End: 02/29/28 Due: 02/28/29

A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT02706873 Org: User:
Start: 02/23/16 End: 11/10/22 Due: 11/10/23

A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06849791 Org: User:
Start: 02/26/25 End: 12/31/25 Due: 12/31/26

A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT06953934 Org: User:
Start: 05/12/25 End: 09/30/25 Due: 09/30/26

A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

Phase: N/A Priority: Normal
NCT ID: NCT06822738 Org: User:
Start: 02/11/25 End: 11/30/28 Due: 11/30/29

Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT06865105 Org: User:
Start: 04/11/25 End: 01/31/28 Due: 01/31/29

A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING

Phase: N/A Priority: Normal
NCT ID: NCT06712628 Org: User:
Start: 11/07/24 End: 12/31/28 Due: 12/31/29

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Phase: N/A Priority: Normal
NCT ID: NCT01848561 Org: User:
Start: 04/29/13 End: 06/24/30 Due: 06/24/31

A Study in Healthy Adult Participants to Assess the Pharmacokinetics, Immunogenicity, Safety, and Tolerability of a Ravagalimab Subcutaneous Formulation in a Pre-Filled Syringe

Phase: N/A Priority: Normal
NCT ID: NCT06402513 Org: User:
Start: 06/24/24 End: 10/08/24 Due: 10/08/25

A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT03069365 Org: User:
Start: 03/28/17 End: 06/05/18 Due: 06/05/19

A Study to Assess the Effects of Multiple Study Drug Regimens in Subjects With Newly Diagnosed Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03818542 Org: User:
Start: 01/22/20 End: 09/23/20 Due: 09/23/21

Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males

Phase: N/A Priority: Normal
NCT ID: NCT01133548 Org: User:
Start: 05/31/10 End: 07/31/10 Due: 07/31/11

Study to Assess Participant/Caregiver/Investigator Satisfaction of Video-Assisted Telenursing in Adult Participants With Parkinson's Disease Treated With Levodopa-Carbidopa Intestinal Gel

Phase: N/A Priority: Normal
NCT ID: NCT04500106 Org: User:
Start: 04/22/21 End: 10/14/21 Due: 10/14/22

A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02163694 Org: User:
Start: 04/08/14 End: 01/25/24 Due: 01/25/25

Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04721015 Org: User:
Start: 02/23/21 End: 08/31/25 Due: 08/31/26

Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT05969223 Org: User:
Start: 08/10/23 End: 11/30/25 Due: 11/30/26